An ejection fraction >35% is unconventional to be considered "preserved," so the results of this trial are inconclusive on whether patients with heart failure and ejection fractions usually ...

Newer therapies for multiple conditions were major stories this year, but long-term HF survival gains seem to have vanished.

Heart Failure, Pathophysiology, Etiology, Reduced Ejection Fraction, Preserved Ejection Fraction, Revascularization, CABG, ...

Meanwhile, if a person has heart failure symptoms and an ejection fraction of 50% or greater, it’s heart failure with ...

Patients admitted to the hospital with acute decompensated heart ... risk factor associated with incident heart failure with preserved ejection fraction (HFpEF). A recent study found that use ...

Some of the top heart failure research looked at statins and semaglutide for heart failure with preserved ejection fraction, ...

The following is a summary of “Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity,” published in the ...

Rheumatoid arthritis (RA) is associated with a higher rate of heart failure subtypes, according to a study published online ...

The following is a summary of “Safety of Diltiazem for Acute Management of Atrial Fibrillation (AF) in Patients with Heart Failure and Reduced Ejection Fraction in the Emergency Department,” published ...

According to AZ, Farxiga is the first drug to show a mortality benefit "across the full ejection fraction range." After the EMPEROR-Preserved ... for Jardiance in acute heart failure (AHF).

Objective: To provide an overview of heart failure with preserved ejection fraction (HFPEF), as well as its pathophysiology, diagnosis, and clinical evidence regarding its pharmacologic management.

A study from Sweden makes the case for increasing doses of heart failure (HF ... with risk of incident heart failure with reduced or preserved ejection fraction in Black adults.